CPC A61K 9/1682 (2013.01) [A61K 9/16 (2013.01); A61K 9/1617 (2013.01); A61K 9/1688 (2013.01); A61K 35/16 (2013.01); B01J 19/06 (2013.01); F26B 3/04 (2013.01); F26B 3/06 (2013.01); F26B 3/12 (2013.01); F26B 5/04 (2013.01); B01J 2219/00177 (2013.01); B65D 51/30 (2013.01); B65D 81/266 (2013.01); F26B 5/065 (2013.01)] | 30 Claims |
1. A reconstituted previously dried plasma product for human transfusion made by the method of:
a) combining i) plasma with ii) one or more stable acidic substances, wherein said one or more stable acidic substances is an acid or acidic salt that effectuates a pH and is physiologically suitable for addition to plasma being dried or physiologically suitable for subjects into which reconstituted plasma is transfused, to thereby create a formulated plasma so that the pH of formulated plasma is between about 5.5 and 7.2,
b) drying the formulated plasma to thereby obtain a dried formulated plasma; and
c) reconstituting said dried formulated plasma with sterile water or alkaline solution to thereby obtain a reconstituted dried plasma product for human transfusion.
|